The Excelera network
consists of point-of-care specialty pharmacies owned by health systems and academic medical centers. The network provides members a nationally scaled infrastructure and support to help them develop best practices, gain access to limited-distribution drugs and biologics, and provide continuity of care for their patients with complex and chronic conditions requiring specialty drugs and biologics. The network also serves as a national platform for collaboration to optimize outpatient specialty drug therapy.
“According to HCUP1, one in five patients who receive debridement of a wound, burn or infection in the hospital are readmitted within 30 days,” said Mike Zagger, SVP Sales & Marketing, Smith & Nephew Advanced Wound Management. “By partnering with Excelera, we have an opportunity to help hospitals and providers deliver accurate treatment, wound management education and comprehensive care plans which may reduce the number of readmissions."
“This partnership with Smith & Nephew is an exciting opportunity to expand our capabilities to care for a new patient base, and collaborate with additional UnityPoint Health providers,” said Ruth Coady, Executive Director of Infusion Services and Specialty Pharmacy, UnityPoint at Home. “It gives us the opportunity to coordinate care with our Wound, Ostomy and Continence Nurses (WOCN) team to improve patient outcomes where gaps in care had previously existed.”
Specialty pharmaceuticals are drugs that require special handing, storage and administration and are often used to treat the most ill and clinically complex patients. Excelera will partner with Smith & Nephew to ensure access to these important treatments is available through Excelera to health system specialty patients.
About Collagenase SANTYL◊ Ointment
SANTYL Ointment is the only FDA-approved prescription biologic indicated for debriding chronic dermal ulcers and severely burned areas. For complete prescribing information please click here
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.8 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN). For more information about Smith & Nephew, please visit our website http://www.smith-nephew.com
, follow @SmithNephewplc on Twitter
or visit SmithNephewplc on Facebook.com
ExceleraRx Corp. supports the Excelera® Specialty Pharmacy Network, a national network of specialty pharmacies based at health systems and academic medical centers, enabling member organizations to gain access to limited distribution drugs. The Excelera network provides national-scale efficiency and collaboration to improve quality and value of outpatient specialty drug therapy for population health outcomes. Excelera’s mission is to “provide tools, technology and best practices around high-performing specialty pharmacy capabilities to network members, so that they can provide integrated, coordinated care to complex patients at the point-of-care leading to improved health outcomes and decreased healthcare costs.” For a current list of Excelera specialty pharmacy network members, or for more information about becoming a member of the Excelera network, visit excelerarx.com
or follow us on LinkedIn